Hysteroscopic Sterilization With Essure: Summary of the US Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance

被引：1
|
作者：
Steward, Rachel [1 ]
机构：
[1] FPA Womens Hlth, Long Beach, CA 90806 USA
来源：
OBSTETRICS AND GYNECOLOGY | 2017年 / 129卷 / 04期
关键词：
D O I：
10.1097/AOG.0000000000001961
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：752 / 753
页数：3
相关论文
共 50 条
  • [1] Hysteroscopic Sterilization With Essure Summary of the U.S. Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance
    Walter, Jessica R.
    Ghobadi, Comeron W.
    Hayman, Emily
    Xu, Shuai
    OBSTETRICS AND GYNECOLOGY, 2017, 129 (01): : 10 - 19
  • [2] Hysteroscopic Sterilization With Essure: Summary of the U. S. Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance Reply
    Walter, Jessica R.
    Ghobadi, Comeron W.
    Hayman, Emily
    Xu, Shuai
    OBSTETRICS AND GYNECOLOGY, 2017, 129 (04): : 753 - 753
  • [3] Power Morcellators, Postmarketing Surveillance, and the US Food and Drug Administration
    Redberg, Rita F.
    Jacoby, Alison F.
    Sharfstein, Joshua M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (04): : 325 - 326
  • [4] US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018
    Skydel, Joshua J.
    Zhang, Audrey D.
    Dhruva, Sanket S.
    Ross, Joseph S.
    Wallach, Joshua D.
    CLINICAL TRIALS, 2021, 18 (04) : 488 - 499
  • [5] Representativeness in Premarketing vs Postmarketing US Food and Drug Administration Trials
    Unger, Joseph M.
    JAMA NETWORK OPEN, 2021, 4 (04)
  • [6] Postmarketing Safety of Vaccines Approved by the US Food and Drug Administration A Cohort Study
    Tau, Noam
    Yahav, Dafna
    Shepshelovich, Daniel
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (06) : 445 - +
  • [7] Postmarketing Colitis Cases Associated With Alpelisib Use Reported to the US Food and Drug Administration
    Sullivan, Kathleen M.
    Dores, Graca M.
    Nayernama, Afrouz
    Prowell, Tatiana M.
    Pradhan, Shan M.
    Osgood, Christy
    Jones, S. Christopher
    JAMA ONCOLOGY, 2022, 8 (10) : 1503 - 1505
  • [8] US FOOD AND DRUG ADMINISTRATION (FDA) POSTMARKETING REQUIREMENTS AND COMMITMENTS RELATED TO DRUG DISPOSITION IN LACTATION AND PREGNANCY
    Ridge, S.
    Ramamoorthy, A.
    Guinn, D.
    Zineh, I.
    Fletcher, E. Pfuma
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S77 - S77
  • [9] Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and food and drug administration regulatory actions
    Wysowski, DK
    Corken, A
    Gallo-Torres, H
    Talarico, L
    Rodriguez, EM
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (06): : 1698 - 1703
  • [10] Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020
    Moneer, Osman
    Lee, ChangWon C.
    Avorn, Jerry
    Kesselheim, Aaron S.
    JAMA NETWORK OPEN, 2021, 4 (04)
12345